Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Non-Current Assets (2022 - 2025)

Historic Non-Current Assets for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $3.4 million.

  • Lucid Diagnostics' Non-Current Assets fell 4187.74% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.0 million, marking a year-over-year decrease of 1196.19%. This contributed to the annual value of $5.6 million for FY2024, which is 711.95% up from last year.
  • Latest data reveals that Lucid Diagnostics reported Non-Current Assets of $3.4 million as of Q3 2025, which was down 4187.74% from $4.8 million recorded in Q2 2025.
  • In the past 5 years, Lucid Diagnostics' Non-Current Assets registered a high of $9.7 million during Q1 2022, and its lowest value of $3.4 million during Q3 2025.
  • Moreover, its 4-year median value for Non-Current Assets was $5.9 million (2023), whereas its average is $6.4 million.
  • Examining YoY changes over the last 5 years, Lucid Diagnostics' Non-Current Assets showed a top increase of 1776.04% in 2025 and a maximum decrease of 4187.74% in 2025.
  • Over the past 4 years, Lucid Diagnostics' Non-Current Assets (Quarter) stood at $8.2 million in 2022, then tumbled by 36.26% to $5.2 million in 2023, then grew by 7.12% to $5.6 million in 2024, then tumbled by 39.72% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, $4.8 million for Q2 2025, and $5.3 million during Q1 2025.